713 related articles for article (PubMed ID: 20971133)
1. Motor neuron trophic factors: therapeutic use in ALS?
Gould TW; Oppenheim RW
Brain Res Rev; 2011 Jun; 67(1-2):1-39. PubMed ID: 20971133
[TBL] [Abstract][Full Text] [Related]
2. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
3. The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo.
Gould TW; Oppenheim RW
J Neurosci; 2004 May; 24(19):4668-82. PubMed ID: 15140938
[TBL] [Abstract][Full Text] [Related]
4. Sporadic amyotrophic lateral sclerosis: is SMN-Gemins protein complex of importance for the relative resistance of oculomotor nucleus motoneurons to degeneration?
Sulejczak D; Chrapusta SJ; Dziewulska D; Rafałowska J
Folia Neuropathol; 2018; 56(4):308-320. PubMed ID: 30786668
[TBL] [Abstract][Full Text] [Related]
5. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
Chennampally P; Sayed-Zahid A; Soundararajan P; Sharp J; Cox GA; Collins SD; Smith RL
Sci Rep; 2021 Sep; 11(1):18168. PubMed ID: 34518579
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection in amyotrophic lateral sclerosis: from pathology to treatment.
Murri L
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):258. PubMed ID: 20406186
[No Abstract] [Full Text] [Related]
8. Quantifying motor neuron loss in ALS.
Narasimhan K
Nat Neurosci; 2006 Mar; 9(3):304. PubMed ID: 16498424
[No Abstract] [Full Text] [Related]
9. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis.
Seeburger JL; Springer JE
Exp Neurol; 1993 Nov; 124(1):64-72. PubMed ID: 8282083
[TBL] [Abstract][Full Text] [Related]
10. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis.
Kim S; Chung AY; Na JE; Lee SJ; Jeong SH; Kim E; Sun W; Rhyu IJ; Park HC
Glia; 2019 Oct; 67(10):1910-1921. PubMed ID: 31290185
[TBL] [Abstract][Full Text] [Related]
11. Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosis.
Harandi VM; Lindquist S; Kolan SS; Brännström T; Liu JX
PLoS One; 2014; 9(10):e109833. PubMed ID: 25334047
[TBL] [Abstract][Full Text] [Related]
12. Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.
Beck M; Karch C; Wiese S; Sendtner M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S55-68. PubMed ID: 11465926
[TBL] [Abstract][Full Text] [Related]
13. Survival and death of mature avian motoneurons in organotypic slice culture: trophic requirements for survival and different types of degeneration.
Brunet N; Tarabal O; Portero-Otín M; Oppenheim RW; Esquerda JE; Calderó J
J Comp Neurol; 2007 Apr; 501(5):669-90. PubMed ID: 17299760
[TBL] [Abstract][Full Text] [Related]
14. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
Lowry KS; Murray SS; McLean CA; Talman P; Mathers S; Lopes EC; Cheema SS
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):127-34. PubMed ID: 11771768
[TBL] [Abstract][Full Text] [Related]
15. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
16. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.
Varcianna A; Myszczynska MA; Castelli LM; O'Neill B; Kim Y; Talbot J; Nyberg S; Nyamali I; Heath PR; Stopford MJ; Hautbergue GM; Ferraiuolo L
EBioMedicine; 2019 Feb; 40():626-635. PubMed ID: 30711519
[TBL] [Abstract][Full Text] [Related]
17. Unchanged Neurotrophic Factors and Their Receptors Correlate With Sparing in Extraocular Muscles in Amyotrophic Lateral Sclerosis.
Harandi VM; Gaied AR; Brännström T; Pedrosa Domellöf F; Liu JX
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6831-6842. PubMed ID: 28002846
[TBL] [Abstract][Full Text] [Related]
18. Malonate-induced cortico-motoneuron death is attenuated by NT-4, but not by BDNF or NT-3.
Van Westerlaak MG; Bär PR; Cools AR; Joosten EA
Neuroreport; 2001 May; 12(7):1355-8. PubMed ID: 11388410
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic factors and amyotrophic lateral sclerosis.
Ekestern E
Neurodegener Dis; 2004; 1(2-3):88-100. PubMed ID: 16908980
[TBL] [Abstract][Full Text] [Related]
20. [Neurotrophic factors and amyotrophic lateral sclerosis (ALS)--therapeutic potential of a new neurotrophic factor: HGF in ALS].
Funakoshi H; Nakamura T
No To Shinkei; 2003 Oct; 55(10):841-5. PubMed ID: 14635512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
